申请人:Bristol-Myers Squibb Company
公开号:US05663151A1
公开(公告)日:1997-09-02
There is provided novel sulfated .alpha.-glycolipid compounds of the formula ##STR1## wherein R is an acyl residue of a fatty acid; R.sup.1 is --(CH.dbd.CH).sub.m --(CH.sub.2).sub.n --CH.sub.3 ; R.sup.2, R.sup.3, R.sup.4 and R.sup.6 are independently at least two --SO.sub.3 H; R.sup.2, R.sup.3, R.sup.4 R.sup.5 and R.sup.6 each are independently hydrogen, unsubstituted or substituted alkanoyl, arylalkyl or arylcarbonyl wherein said substituent is selected from halogen, C.sub.1-4 alkyl, trifluoromethyl, hydroxy and C.sub.1-4 alkoxy; m is an integer of 0 or 1; n is an integer of from 5 to 14, inclusive; or a non-toxic pharmaceutically acceptable salt, solvate or hydrate thereof which are inhibitors of selectin-mediated cellular adhesion and are useful in the treatment or prevention of inflammatory diseases and other pathological conditions in mammals.
提供了一种新型的磺酸化α-糖脂化合物,其化学式为##STR1##其中R是脂肪酸的酰基残基;R.sup.1是--(CH.dbd.CH).sub.m--(CH.sub.2).sub.n--CH.sub.3;R.sup.2、R.sup.3、R.sup.4和R.sup.6独立地至少有两个--SO.sub.3 H;R.sup.2、R.sup.3、R.sup.4、R.sup.5和R.sup.6各自独立地是氢、未取代或取代的烷酰基、芳基烷基或芳基羰基,其中所述取代基选自卤素、C.sub.1-4烷基、三氟甲基、羟基和C.sub.1-4烷氧基;m是0或1的整数;n是从5到14的整数,包括在内;或其非毒性药学上可接受的盐、溶剂化合物或水合物,它们是选择素介导的细胞粘附的抑制剂,并且在哺乳动物的炎症性疾病和其他病理条件的治疗或预防中是有用的。